Приказ основних података о дисертацији

Sociodemographic profile of opiate addicts at increased risk of infection with HBV, HCV, HIV, Тreponema pallidum, Cryptococcus neoformans, Pneumocystis carini and WNV

dc.contributor.advisorRistanović, Elizabeta
dc.contributor.otherBalint, Bela
dc.contributor.otherČanović, Predrag
dc.contributor.otherJovanović, Ivan
dc.creatorBorovčanin, Nemanja
dc.date.accessioned2019-06-10T16:07:05Z
dc.date.available2019-06-10T16:07:05Z
dc.date.available2020-07-03T15:16:15Z
dc.date.issued2019-03-01
dc.identifier.urihttps://nardus.mpn.gov.rs/handle/123456789/11183
dc.identifier.urihttp://eteze.kg.ac.rs/application/showtheses?thesesId=6698
dc.identifier.urihttps://fedorakg.kg.ac.rs/fedora/get/o:1123/bdef:Content/download
dc.description.abstractUvod. Zavisnici od opijata predstavljaju visokorizičnu grupu zbog međusobnih infekcija krvno-prenosivim bolestima, vertikalne transmisije patogena, kao i zbog mogućnosti da budu potencijalni donori krvi (naročito kao plaćeni davaoci). Cilj. Cilj našeg istraživanja bio je određivanje socio-demografskog profila 99 zavisnika od opijata Šumadijskog okruga lečenih u Kliničkom centru Kragujevac supstitucionom terapijom metadonom i buprenorfinom, kao i određivanje prevalence infekcija krvno-prenosivim patogenima: virus hepatitisa tip B, virus hepatitisa tip C, virus stečene imunodeficijencije (HBV, HCV, HIV) i sifilis (Treponema pallidum), kao i Cryptococcus neoformans, Pneumocystis carini i virus Zapadnog Nila (West Nile Virus – WNV). Metode: Ispitanici su odgovarali na pitanja iz Pompidu upitnika i podaci iz ovog upitnika su korišćeni za analizu osnovnih socio-demografskih karakteristika. Svi uzorci su testirani korišćenjem ELISA (Enzyme – Linked ImmunoSorbent Assay)/CIA (Chemiluminescent Immuno – Assay) testova za virus hepatitisa tip B, virus hepatitisa tip C, virus stečene imunodeficijencije (HBV, HCV, HIV) i sifilis (Treponema pallidum), kao i korišćenjem PCR (Polymerase Chain Reaction) za HBV, HCV, HIV, Cryptococcus neoformans, Pneumocystis carini i virus Zapadnog Nila (West Nile Virus – WNV). Rezultati: Najveći broj ispitanika je bio muškog pola (81,8 %), starosti 32 (19 – 57) godine, 99 % je živelo u gradu, nezaposlenih je bilo 58,6 %, sa završenom srednjom školom 67,7 %, a korisnika neadekvatne primene igala 34,3 %. Netestiranih na HBV je 39,4 %, na HCV 36,4 %, HIV 28,3 %, a samo njih 4 (4 %) je primilo vakcinu protiv HBV. Što se tiče analiza na prisustvo HBV infekcije, ELISA/CIA i PCR negativnih je bilo 66, HBV ELISA/CIA i PCR pozitivnih je bilo 19, HBV ELISA/CIA-negativnih / PCRpozitivnih 12 i HBV ELISA/CIA-pozitivnih / PCR-negativnih 2 ispitanika. Testiranje na HCV infekciju je pokazalo sledeće: ELISA/CIA i PCR negativnih ispitanika je bilo 15, HCV ELISA/CIA i PCR pozitivnih je bilo 58, HCV ELISA/CIA-negativnih / PCRpozitivnih 11, a HCV ELISA/CIA-pozitivnih / PCR-negativnih 15. Svi ispitanici su bili negativni na HIV (ELISA/CIA i PCR testiranje), kao i na patogene oportunističkih infekcija (Cryptococcus neoformans; Pneumocystis carini; PCR testiranje) i na prisustvo WNV (PCR testiranje). Jedan ispitanik je bio pozitivan na sifilis (ELISA testiranje). Zaključak: Naši rezultati su pokazali da je pozitivnost na prisustvo patogena krvnoprenosivih bolesti HBV i HCV visoka u ispitivanoj grupi zavisnika od opijata i iznosi 33,4 % i 84,8 %. Preporuka bi bila da oni budu periodično testirani na prisustvo HBV, HCV i HIV, komplementarnim ELISA/CIA i PCR testovima, obzirom na izvestan stepen diskrepance u dobijenim rezultatima serološkog i molekulskog testiranja.sr
dc.description.abstractBackground/Aim. Intravenous drug users (IDUs) are still a high risk-group for cross-reacting blood-borne infections, for vertical pathogen transmission, as well as for potentially blood/plasma donation (particularly as "payed" donors). The aim of our study was to establish the profile of opiate addict and prevalence of blood-borne pathogens – Hepatitis B virus (HBV), Hepatitis C virus (HCV), Human Immunodeficiency Virus (HIV), Treponema pallidum, Cryptococcus neoformans, Pneumocystis carini and West Nile Virus – WNV among 99 patients on substitution therapy with methadone and buprenorphine from Shumadia District. Methods. The Treatment Demand Indicator (TDI) of Pompidou-questionnaire was used to assess the history of drug abuse and risk behavior. All blood samples were tested for HBV, HCV, HIV and Treponema pallidum by Enzyme-Linked ImmunoSorbent Assay (ELISA) or Chemiluminescent Immuno-Assay (CIA). Investigations were also performed for HBV, HCV, HIV, Cryptococcus neoformans, Pneumocystis carini and West Nile Virus – WNV by molecular testing – Polymerase Chain Reaction (PCR) method. Results. The majority of patients were male (81.8 %), median age 32 (19 – 57) years, lived in a city (99 %), unemployed (58.6 %), with finished secondary school (67.7 %), unsafe injecting practices (34.3 %) and never previously tested for HBV (39.4 %), HCV (36.4 %) nor HIV (28.3 %); only four percentage of them previously got HBV-vaccine. Complementary testings resulted with the following results: HBV ELISA/CIA and PCR negativity for 66 patients and positive results (by ELISA/CIA and PCR) for 19 patients. However, a difference was observed in ELISA/CIAnegative / PCR-positive result for 12 and ELISA/CIA-positive / PCR-negative for two patients, respectively. Further, negative results for HCV (ELISA/CIA and PCR testing) were found in 15 IDUs and positive results (using both methods) were found in 58 patients. Different results for ELISA/CIA-negative / PCR-positive results were found in 11 IDUs and ELISA/CIApositive / PCR-negative results were found in 15 patients. All investigated IDUs were negative for HIV (ELISA/CIA and PCR testing) and for pathogens of opportunistic infection (Cryptococcus neoformans; Pneumocystis carini; PCR testing), as well as for West Nile Virus (PCR testing). Just one IDU was positive for syphilis (ELISA and confirmatory testing). Conclusion. This study undoubtedly confirmed the effectiveness and improved safety of originally designed complementary (ELISA/CIA and PCR) pathogen monitoring system. Our study demonstrated that the positivity for HBV and HCV is still very high (33.4 % and 84.8 %, respectively) in IDUs. Thus, we suggest that drug users have to be periodically screened using a complementary serological/molecular testing, also concerning differences/discrepancies in results obtained using these methods.en
dc.formatapplication/pdf
dc.languagesr
dc.publisherУниверзитет у Крагујевцу, Факултет медицинских наукаsr
dc.rightsopenAccessen
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceУниверзитет у Крагујевцуsr
dc.subjectzavisnici od opijatasr
dc.subjectintravenous drug usersen
dc.subjectblood-borne pathogensen
dc.subjectHBVen
dc.subjectHCVen
dc.subjectHIVen
dc.subjectkrvno-prenosivi patogenisr
dc.subjectHBVsr
dc.subjectHCVsr
dc.subjectHIVsr
dc.titleSociodemografski profil zavisnika od opijata koji su u povećanom riziku od infekcije HBV, HCV, HIV, Treponema pallidum, Cryptococcus neoformans, Pneumocystis carini i WNVsr
dc.title.alternativeSociodemographic profile of opiate addicts at increased risk of infection with HBV, HCV, HIV, Тreponema pallidum, Cryptococcus neoformans, Pneumocystis carini and WNVen
dc.typedoctoralThesisen
dc.rights.licenseBY-NC-ND
dc.identifier.fulltexthttps://nardus.mpn.gov.rs/bitstream/id/48882/Disertacija.pdf
dc.identifier.fulltexthttp://nardus.mpn.gov.rs/bitstream/id/48882/Disertacija.pdf
dc.identifier.fulltexthttps://nardus.mpn.gov.rs/bitstream/id/48883/bitstream_48883.pdf
dc.identifier.rcubhttps://hdl.handle.net/21.15107/rcub_nardus_11183


Документи за докторску дисертацију

Thumbnail
Thumbnail

Ова дисертација се појављује у следећим колекцијама

Приказ основних података о дисертацији